Retail fund manager MIG Verwaltungs AG and Global Asset Management have invested a further €8m in biotechnology company Antisense Pharma GmbH.
In addition to Famar Italia, the Italian subsidiary of Famar, the deal also includes Famar Properties
There are reportedly concerns over the accessories distributor's revenues in the wake of coronavirus
Deal will see minority shareholder Arctos Equity Partners exit the business
Sale ends a four-year holding period for the GP, which invested in the company via its first fund